Received Jan 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | Z006001 | — |
No clinical side effects noted; ROTATEQ was given to a patient who was 15 weeks 2 days old; This Spontaneous report was received from Nurse and referred to a 15 weeks patient of unknown gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 13-Jan-2025, the patient was vaccinated with the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent Oral solution (ROTATEQ) (1.00 dosage form) (total) (Batch/Lot Number: Z006001) (Expiration date: 11-Jul-2026) for prophylaxis (Inappropriate age at vaccine administration). No clinical side effects noted (No adverse event).